Silva Francisco's Form 4 filing
BioRestorative Therapies, Inc. (BRTX) · filed Apr 10, 2024
- Accession no.
- 0001021771-24-000091
- Filed
- Apr 10, 2024
- Trade date
- Apr 8-9, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market purchases total $10.2K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Silva FranciscoCIK 0001527241 | Director, Officer (VP of Research and Development) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 8, 2024 | Common Stock | PPurchaseAcquired | +476 | $1.13 | +$537.88 | 147,927 | Direct | |
| Apr 8, 2024 | Common Stock | PPurchaseAcquired | +1,232 | $1.17 | +$1,441.44 | 149,159 | Direct | |
| Apr 9, 2024 | Common Stock | PPurchaseAcquired | +6,600 | $1.25 | +$8,250 | 155,759 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.